We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Demonstrates New SENTiNAT 200 and STAT-NAT Kits for Infectious Diseases

By LabMedica International staff writers
Posted on 14 Nov 2023

Sentinel Diagnostics (Milano, Italy) is demonstrating the new SENTiNAT 200 and its panel of STAT-NAT kits for infectious diseases at MEDICA 2023. More...

SENTiNAT 200 is a fully automated sample-to-result system for DNA/RNA extraction, PCR setup, and amplification that includes two integrated thermal cyclers and the analysis software FastFinder. The system combines throughput, automation, and flexibility to better adapt to the various laboratory needs. It can perform multiparametric analysis of up to 15 viruses in the same run, processing from one up to 48 samples in four hours. The intuitive software that guides the operator through all the phases of the instrument setup and the barcode reader for samples and reagents help to reduce human errors. The operator can access to the data available on the Cloud anytime anywhere, to optimize the reporting time keeping full control over the results.

SENTiNAT 200 is designed to work with STAT-NAT SN200 kits which are also being highlighted at MEDICA 2023. STAT-NAT (Stabilized Amplification Technology) kits are based on Sentinel’s proprietary technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. In addition to the STAT-NAT SN200 product line designed to be used with SENTIENT 200, Sentinel is showcasing the STAT-NAT kits designed for manual use and useful for low throughput requirements and STAT-NAT Flex kits designed for the semi-automated use and useful for low to medium throughput requirements.

Related Links:
Sentinel Diagnostics 


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.